Citadel Advisors - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$8,394,581
-82.4%
203,505
-76.2%
0.00%
-88.9%
Q2 2023$47,652,181
-37.8%
853,370
-37.8%
0.01%
-47.1%
Q1 2023$76,550,965
+39.6%
1,372,127
-8.8%
0.02%
+41.7%
Q4 2022$54,820,372
+329.2%
1,504,401
+235.4%
0.01%
+500.0%
Q3 2022$12,773,000
+24.5%
448,481
+97.8%
0.00%
-33.3%
Q2 2022$10,260,000
+46.0%
226,733
+145.4%
0.00%
+200.0%
Q1 2022$7,029,000
-46.9%
92,400
+4.0%
0.00%
-50.0%
Q4 2021$13,231,000
-56.4%
88,816
-57.4%
0.00%
-66.7%
Q3 2021$30,371,000
+32.3%
208,622
+78.0%
0.01%
+50.0%
Q2 2021$22,957,000
+202.5%
117,230
+179.6%
0.00%
+100.0%
Q1 2021$7,588,000
-78.9%
41,926
-83.5%
0.00%
-80.0%
Q4 2020$35,922,000
+69.3%
253,681
+49.1%
0.01%
+66.7%
Q3 2020$21,216,000
+485.9%
170,165
+319.6%
0.01%
+500.0%
Q2 2020$3,621,000
-17.8%
40,557
-42.6%
0.00%
-50.0%
Q1 2020$4,404,000
+15.9%
70,661
+41.8%
0.00%
+100.0%
Q4 2019$3,799,000
-28.5%
49,818
-52.8%
0.00%
-66.7%
Q3 2019$5,316,000105,4700.00%
Other shareholders
10X GENOMICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Venrock Management VI, LLC 962,309$188,439,00095.08%
Foresite Capital Management II, LLC 1,753,528$343,376,00092.37%
Foresite Capital Management I, LLC 750,000$146,865,00088.53%
12 West Capital Management LP 1,922,000$376,366,00015.78%
Financial Consulate Inc. 141,258$27,661,0009.97%
FINANCIAL CONSULATE, INC 141,258$27,661,0009.97%
Meritech Capital Associates V L.L.C. 1,793,871$351,276,0007.51%
Andar Capital Management HK Ltd 51,000$9,987,0006.81%
JS Capital Management LLC 540,589$105,858,0005.12%
Renaissance Capital LLC 97,281$19,050,0003.01%
View complete list of 10X GENOMICS INC shareholders